Executive Summary: Key Legal and Evidentiary Issues

• Injunction to restrain future speech was denied due to the high legal threshold in defamation matters.

• Plaintiffs did not prove that the respondent’s defences—justification, fair comment, responsible communication—would inevitably fail.

• Statements on alleged procurement impropriety and the safety of imported children’s acetaminophen did not warrant an interlocutory restraint.

• The existence of public investigations into procurement issues weighed against injunctive relief.

• Differences in product formulation (concentration and viscosity) were not enough to prove the defendant's reporting lacked any sustainable defence.

• Claims over publication of home addresses and family information were dismissed as the data was publicly sourced and not legally harassing.

Facts of the case

MHCare Medical Corporation and its sole director, Sam Mraiche, brought a defamation action against journalist Nathan Pike and his media platform, Breakdown Media. They alleged that Pike’s publications damaged their reputations and applied for an interlocutory injunction to restrain him from posting or reposting any content—visual, audio, or written—relating to MHCare, Mraiche, their employees, or contractors.

The underlying defamation claim, filed in December 2024, was still in its early stages. On February 14, 2025, the plaintiffs were granted an emergency interlocutory injunction. However, the matter came before Justice Bokenfohr on February 28, 2025, for a de novo hearing, where she reviewed the application afresh and without regard to the prior order. Her oral reasons were delivered on March 3, 2025.

Statements at issue

The plaintiffs identified two main categories of allegedly defamatory statements:

1. Statements that MHCare, in collaboration with Alberta Health Services (AHS), imported and distributed a dangerous acetaminophen product for children from Turkey during the pandemic.

2. Statements suggesting that MHCare and Mraiche improperly influenced government contracting and procurement processes to benefit themselves.

The plaintiffs argued these statements were defamatory and sought to stop further publication. They also alleged that personal information, such as home addresses and family employment details, had been unlawfully disseminated, justifying additional restraints.

Legal framework and defences raised

Justice Bokenfohr reviewed the applicable legal test for granting an interlocutory injunction in defamation cases. As established in Peterson v McNallie, 2024 ABKB 127 and Peyrow v Kaklin, 2022 ABKB 823, such an injunction may only be granted where:

• The statements are clearly defamatory;

• The defendant expresses an intention to justify the statements, and;

• The plaintiff proves the defences are bound to fail (i.e., “inevitably fail” or “beyond doubt” not sustainable).

This strict threshold exists to preserve the principle of freedom of expression under the common law and the Charter.

The defendant, Pike, indicated an intention to rely on the defences of justification, fair comment, and responsible communication in the public interest. These defences are rooted in the idea that even harmful statements may be protected if they are based on facts, honestly held opinions, or responsibly reported matters of public concern.

Court’s analysis and findings

On the procurement-related statements, the judge assumed (without deciding) that the statements were defamatory. However, the plaintiffs failed to establish that Pike’s defences would inevitably fail. The issues raised were the subject of ongoing governmental and Auditor General reviews, making them matters of public concern and debate. Injunctive relief was therefore denied.

Regarding the acetaminophen imported from Turkey—referred to by Pike as “Tylenot” or “Turkish Tylenot”—the Court found these statements to be defamatory. They suggested that the product was dangerous and put children at risk, which could damage the plaintiffs’ reputations. However, Pike’s affidavit stated that he relied on public documents from AHS and Blue Cross to support his claims. The documents revealed the product had a different concentration and viscosity, requiring altered dosing and pharmacist intervention. Pike argued these differences created a health risk, justifying his commentary.

The Court concluded that although the plaintiffs had a viable argument that the defences might fail, they had not shown it was beyond doubt. Whether Pike’s interpretation amounted to a sustainable defence is a matter for trial.

Additional relief sought

The plaintiffs also sought to restrain Pike from publishing:

• The home address of an MHCare contractor, Blayne Iskiw; and

• Information about Mraiche’s family members, including their public employment and political donations.

The Court found that the home address had been posted as part of a Corporate Registry search and that Pike undertook to remove it and avoid posting home addresses in future. The information about family members was derived from publicly available sources and included work phone numbers and political contributions. There was no publication of private contact information. The Court held that this did not amount to harassment and declined to issue a restraining order.

Although the plaintiffs expressed concern about hostile and threatening comments, the judge noted that none of these were made by Pike himself. However, she did warn Pike that he is legally obligated to monitor comments on his social media and remove any that incite or threaten violence, referencing Buy Beauty LCC v Dong, 2024 BCSC 815.

Conclusion

The Court dismissed the application for an interlocutory injunction in full. The plaintiffs had not met the high standard required to limit speech before trial, and the potential availability of viable defences by the defendant required the matter to proceed through the normal course of litigation. Separate requests for restraining orders related to address and family information were also dismissed as legally unsustainable under current defamation and harassment standards.